Nuclear Retinoid Receptors are Involved inN-(4-Hydroxyphenyl) Retinamide (Fenretinide)-Induced Gene Expression and Growth Inhibition in HL-60 Acute Myeloid Leukemia Cells

This publication has 8 references indexed in Scilit:

• N-4-Hydroxyphenylretinamide Enhances Retinoic Acid-Induced Differentiation and Retinoylation of Proteins in the Human Acute Promyelocytic Leukemia Cell Line, NB4, by a Mechanism That May Involve Inhibition of Retinoic Acid Catabolism
  Biochemical and Biophysical Research Communications, 1997
• Differential Effects of Retinoic Acid (RA) andN-(4-Hydroxyphenyl)retinamide (4-HPR) on Cell Growth, Induction of Differentiation, and Changes in p34cdc2, Bcl-2, and Actin Expression in the Human Promyelocytic HL-60 Leukemic Cells
  Biochemical and Biophysical Research Communications, 1996
• Activation of Retinoid X Receptors Induces Apoptosis in HL-60 Cell Lines
  Molecular and Cellular Biology, 1995
• Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2
  Blood, 1995
• Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity
  Blood, 1992
• Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells.
  Molecular and Cellular Biology, 1992
• Suppression of rat mammary cancer development by N-(4-hydroxy-phenyDretinamide (4-HPR) following surgical removal of first palpable tumor
  Carcinogenesis: Integrative Cancer Research, 1989
• Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
  Journal of Immunological Methods, 1983